Current Drug Shortages reported to PharmSaver


Sort By: Date | Name

Wednesday, October 14, 2026

FDA Dexmedetomidine Hydrochloride Injection (NDC 83634060002) AVENACY
FDA Everolimus Tablet (NDC 49884028302) PAR HEALTH USA
FDA Everolimus Tablet (NDC 49884016002) PAR HEALTH USA
FDA Everolimus Tablet (NDC 49884015802) PAR HEALTH USA
FDA Everolimus Tablet (NDC 49884015902) PAR HEALTH USA

Wednesday, October 7, 2026

FDA Felodipine Tablet Extended Release (NDC 00603358121) ENDO USA
FDA Felodipine Tablet Extended Release (NDC 00603358221) ENDO USA
FDA Felodipine Tablet Extended Release (NDC 00603358228) ENDO USA
FDA Felodipine Tablet Extended Release (NDC 00603358128) ENDO USA
FDA Felodipine Tablet Film Coated Extended Release (NDC 00603358321) ENDO USA
FDA Felodipine Tablet Film Coated Extended Release (NDC 00603358328) ENDO USA

Friday, October 2, 2026

FDA Fluocinonide Ointment (NDC 00093026492) TEVA PHARMACEUTICALS USA
FDA Fluocinonide Ointment (NDC 00093026430) TEVA PHARMACEUTICALS USA
FDA Fluocinonide Ointment (NDC 00093026415) TEVA PHARMACEUTICALS USA

Tuesday, September 29, 2026

FDA Ivermectin Tablet (NDC 00006003201) MERCK SHARP & DOHME

Monday, September 21, 2026

FDA Arsenic Trioxide Injection (NDC 63323063710) FRESENIUS KABI USA

Friday, September 18, 2026

FDA Rivaroxaban For Suspension (NDC 50458057501) JANSSEN
FDA Rivastigmine Film Extended Release (NDC 00378907093) MYLAN

Wednesday, September 16, 2026

FDA Melphalan Hydrochloride Injection (NDC 63323076020) FRESENIUS KABI USA
FDA Mesalamine Capsule Extended Release (NDC 54092018981) TAKEDA PHARMACEUTICALS AMERICA
FDA Mesalamine Capsule Extended Release (NDC 54092019112) TAKEDA PHARMACEUTICALS AMERICA

Friday, September 11, 2026

FDA Cisatracurium Besylate Injection (NDC 00409109802) HOSPIRA
FDA Micafungin Sodium Injection (NDC 42023023010) PAR HEALTH USA
FDA Micafungin Sodium Injection (NDC 42023022910) PAR HEALTH USA

Wednesday, September 9, 2026

FDA Imipenem Anhydrous Cilastatin and Relebactam Anhydrous Injec (NDC 00006385602) MERCK SHARP & DOHME

Tuesday, September 1, 2026

FDA Glycerol Phenylbutyrate Oral Liquid (NDC 75987005006) AMGEN
FDA Insulin Glargine-aglr Injection (NDC 00002898005) LILLY
FDA Insulin Lispro Injection (NDC 00002775205) LILLY
FDA Insulin Lispro Protamine and Insulin Lispro Injection (NDC 00002823305) LILLY

Monday, August 31, 2026

FDA Medroxyprogesterone Acetate Tablet (NDC 00009006501) PFIZER U.S.
FDA Medroxyprogesterone Acetate Tablet (NDC 00009005101) PFIZER U.S.
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963067711) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963067611) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963067696) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963067796) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963070911) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963067811) ACTAVIS
FDA Metoprolol Succinate Tablet Extended Release (NDC 45963070996) ACTAVIS
FDA Palovarotene Capsule (NDC 15054002501) IPSEN BIOPHARMACEUTICALS
FDA Potassium Chloride Sodium Chloride Calcium Chloride and Magn (NDC 65219025810) FRESENIUS KABI USA

Thursday, August 27, 2026

FDA Pentostatin Injection (NDC 00409080101) HOSPIRA

Tuesday, August 25, 2026

FDA Liraglutide Injection (NDC 00169280015) NOVO NORDISK
FDA Mesalamine Capsule Extended Release (NDC 00378137578) MYLAN

Monday, August 24, 2026

FDA Disopyramide Phosphate Capsule Extended Release (NDC 00025273231) PFIZER U.S.
FDA Disopyramide Phosphate Capsule Extended Release (NDC 00025274231) PFIZER U.S.

Drug Shortages can occur because of manufacturing and quality problems, delays and discontinuations.

Items shown in shortage are based on information provided by several sources including the official FDA Drug Shortages site and wholesalers when they list manufacturer out and discontinued items.

Shortage notifications and updates may be reported to us using Contact Us.